Department of Neurology, Dongzhimen Hospital/Institute of Brain and Cognitive Disorders, Beijing University of Chinese Medicine, Beijing, China.
3 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
A systematic narrative review of mechanistic literature on five deubiquitinases in cancer, proposing therapeutic targeting strategies without reporting clinical trial data or empirical evidence of efficacy.
Preclinical discovery and optimization study with in vitro, xenograft, and animal toxicology data, but no human clinical evidence; Phase 1 trial is only stated as 'underway' with no results reported.